INGN

Inogen Inc

5.84

USD

-0.93

-13.71%

Nov 06, 11:56 UTC -5

Open

Inogen Inc (INGN) Earnings

INGN Earnings Reports

Positive Surprise Ratio

INGN beat 32 of 44 last estimates.

73%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Inogen Inc earnings per share and revenue

On Nov 05, 2026, INGN reported earnings of -0.56 USD per share (EPS) for Q3 26, missing the estimate of -0.14 USD, resulting in a -285.41% surprise. Revenue reached 77.19 million, compared to an expected 94.09 million, with a -17.97% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Tandem Diabetes Care, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.10

Surprise

+59.55%

Artivion, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.06

Actual

$0.08

Surprise

+228.00%

Mobia Medical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.04%

Treace Medical Concepts, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.67%

Envoy Medical, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.68

Actual

-$0.50

Surprise

+26.47%

Mettler-Toledo International

Report Date

Nov 05, 2026 For Q3 26

Estimate

$12.21

Actual

$12.57

Surprise

+2.90%

Teleflex Incorporated

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.92

Actual

$2.63

Surprise

+36.82%

Pulse Biosciences, Inc Common Stock (DE)

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.32

Surprise

+14.05%

TransMedics Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.29

Actual

$0.51

Surprise

+71.31%

CVRx, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.52

Surprise

-2.91%

FAQ

What were Inogen Inc's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Inogen Inc reported EPS of -$0.56, missing estimates by -285.41%, and revenue of $77.19M, -17.97% below expectations.

How did the market react to Inogen Inc's Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Inogen Inc expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Inogen Inc's next earnings report?

Based on -- analysts, Inogen Inc is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.